Torley Helen bought HALO
April 1, 2026 · Form 4 insider transaction
Torley Helen bought 20,000 shares of Halozyme Therapeutics, Inc. at $12.07 per share, a transaction worth $241.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$12.07
Total value
$241.4K
InsiderTorley Helen
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 1, 2026
Filing dateApril 2, 2026
Shares owned after787,780
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.